 
                        | Product NDC: | 68828-106 | 
| Proprietary Name: | Jafra | 
| Non Proprietary Name: | Titanium Dioxide, Octinoxate | 
| Active Ingredient(s): | 2; 6.4 mL/80mL; mL/80mL & nbsp; Titanium Dioxide, Octinoxate | 
| Administration Route(s): | TOPICAL | 
| Dosage Form(s): | LIQUID | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 68828-106 | 
| Labeler Name: | Jafra Cosmetics International Inc | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | part352 | 
| Marketing Category: | OTC MONOGRAPH NOT FINAL | 
| Start Marketing Date: | 20120730 | 
| Package NDC: | 68828-106-02 | 
| Package Description: | 10 BOTTLE in 1 PACKAGE (68828-106-02) > 8 mL in 1 BOTTLE (68828-106-01) | 
| NDC Code | 68828-106-02 | 
| Proprietary Name | Jafra | 
| Package Description | 10 BOTTLE in 1 PACKAGE (68828-106-02) > 8 mL in 1 BOTTLE (68828-106-01) | 
| Product NDC | 68828-106 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Titanium Dioxide, Octinoxate | 
| Dosage Form Name | LIQUID | 
| Route Name | TOPICAL | 
| Start Marketing Date | 20120730 | 
| Marketing Category Name | OTC MONOGRAPH NOT FINAL | 
| Labeler Name | Jafra Cosmetics International Inc | 
| Substance Name | OCTINOXATE; TITANIUM DIOXIDE | 
| Strength Number | 2; 6.4 | 
| Strength Unit | mL/80mL; mL/80mL | 
| Pharmaceutical Classes |